← Leaderboards
Susan L Slager
Mayo Clinic Rochester
$16,375,515
Attributed
$27,173,534
Total exposure
10
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.9M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$27,173,534 · 10
By mechanism
R01$15,465,635 · 5
U01$7,091,882 · 1
RF1$3,354,111 · 1
K07$662,646 · 1
R21$599,260 · 2
Top collaborators
- Esteban Braggio14 shared
- Tait D Shanafelt6 shared
- Neil Edward Caporaso4 shared
- Christopher C. Oakes4 shared
- Geffen Kleinstern2 shared
- Aswin Sekar1 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Tait D Shanafelt$9,008,119
- Amy C Degnim$9,208,153
- Esteban Braggio$6,330,549
- V. Shane Pankratz$4,461,337
- Hilal Maradit Kremers$11,722,206
Others in their field
Top investigators on “Chronic Lymphocytic Leukemia”
- David Heimbrook · Leidos Biomedical Research, Inc.$30,232,142
- Catherine Ju-Ying Wu · Broad Institute, Inc.$27,924,233
- John C Byrd · University Of Cincinnati$23,347,401
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
- Thomas J. Kipps · University Of California San Diego$14,051,126
- Brenda J. Weigel · University Of Minnesota$13,972,330
Research focus
Chronic Lymphocytic LeukemiaGeneticEtiologyGenotypeGenesSingle Nucleotide PolymorphismAffectSusceptibility GeneGenome Wide Association StudyInheritedBaseB-LymphocytesResourcesLeukemiaRisk FactorsCaucasiansInsightMalignant NeoplasmsVariantPublic HealthHigh RiskPredispositionLymphocytosisBiology
Grant awards (42)
Prevalence, etiology, and clinical implications of low count monoclonal B-cell lymphocytosis (MBL)$3,354,111
RF1 · FY2025 · AG · contact PI
The genetic and epigenetic etiology of progression from the precursor state to chronic lymphocytic leukemia (CLL)$1,651,283
R01 · FY2025 · CA · contact PI
Germline and Somatic Genomic Studies in CLL$662,342
R01 · FY2025 · CA · contact PI
Clonal growth and prediction of monoclonal B-cell lymphocytosis$193,041
R21 · FY2025 · CA · contact PI
The genetic and epigenetic etiology of progression from the precursor state to chronic lymphocytic leukemia (CLL)$783,300
R01 · FY2024 · CA · contact PI
Germline and Somatic Genomic Studies in CLL Minorities$629,224
R01 · FY2024 · CA · contact PI
The genetic and epigenetic etiology of progression from the precursor state to chronic lymphocytic leukemia (CLL)$804,919
R01 · FY2023 · CA · contact PI
Germline and Somatic Genomic Studies in CLL Minorities$649,094
R01 · FY2023 · CA · contact PI
Integration of germline and tumor genomes in CLL$622,223
R01 · FY2023 · CA · contact PI
The genetic and epigenetic etiology of progression from the precursor state to chronic lymphocytic leukemia (CLL)$870,073
R01 · FY2022 · CA · contact PI
Germline and Somatic Genomic Studies in CLL Minorities$649,094
R01 · FY2022 · CA · contact PI
Integration of germline and tumor genomes in CLL$633,873
R01 · FY2022 · CA · contact PI
Prevalence, etiology, and clinical implications of low count monoclonal B-cell lymphocytosis (MBL)$464,153
R01 · FY2022 · AG · contact PI
Genetic Biomarkers for Risk of CLL Progression among high-count MBLs$182,662
R21 · FY2022 · CA · contact PI
Germline and Somatic Genomic Studies in CLL Minorities$677,092
R01 · FY2021 · CA · contact PI
Prevalence, etiology, and clinical implications of low count monoclonal B-cell lymphocytosis (MBL)$666,402
R01 · FY2021 · AG · contact PI
Integration of germline and tumor genomes in CLL$639,092
R01 · FY2021 · CA · contact PI
Genetic Biomarkers for Risk of CLL Progression among high-count MBLs$223,557
R21 · FY2021 · CA · contact PI
Prevalence, etiology, and clinical implications of low count monoclonal B-cell lymphocytosis (MBL)$699,156
R01 · FY2020 · AG · contact PI
Integration of germline and tumor genomes in CLL$639,092
R01 · FY2020 · CA · contact PI
Prevalence, etiology, and clinical implications of low count monoclonal B-cell lymphocytosis (MBL)$699,296
R01 · FY2019 · AG · contact PI
Integration of germline and tumor genomes in CLL$653,840
R01 · FY2019 · CA · contact PI
Prevalence, etiology, and clinical implications of low count monoclonal B-cell lymphocytosis (MBL)$698,932
R01 · FY2018 · AG · contact PI
Genetic Epidemiology of Chronic Lymphocytic Leukemia$596,741
U01 · FY2015 · CA · contact PI
Genetic Epidemiology of Chronic Lymphocytic Leukemia$569,494
U01 · FY2014 · CA · contact PI
Genetic Epidemiology of Chronic Lymphocytic Leukemia$580,830
U01 · FY2013 · CA · contact PI
Genetic Epidemiology of Chronic Lymphocytic Leukemia$662,151
U01 · FY2012 · CA · contact PI
Pooling and expansion of Chronic Lymphocytic Leukemia GWA data$536,926
R01 · FY2012 · CA · contact PI
Genetic Epidemiology of Chronic Lymphocytic Leukemia$667,854
U01 · FY2011 · CA · contact PI
Pooling and expansion of Chronic Lymphocytic Leukemia GWA data$547,062
R01 · FY2011 · CA · contact PI
Genetic Epidemiology of Chronic Lymphocytic Leukemia$640,314
U01 · FY2010 · CA · contact PI
Pooling and expansion of Chronic Lymphocytic Leukemia GWA data$589,167
R01 · FY2010 · CA · contact PI
Genetic Epidemiology of Chronic Lymphocytic Leukemia$630,646
U01 · FY2009 · CA · contact PI
Genetic Epidemiology of Chronic Lymphocytic Leukemia$616,035
U01 · FY2009 · CA · contact PI
Genetic Epidemiology of Chronic Lymphocytic Leukemia$622,973
U01 · FY2008 · CA · contact PI
Genetic Epidemiology of Chronic Lymphocytic Leukemia$831,249
U01 · FY2007 · CA · contact PI
Genetic Epidemiology of Chronic Lymphocytic Leukemia$673,595
U01 · FY2006 · CA · contact PI
Statistical Genetic Methods for Cancer Gene Studies$116,381
K07 · FY2006 · CA · contact PI
Statistical Genetic Methods for Cancer Gene Studies$137,376
K07 · FY2005 · CA
Statistical Genetic Methods for Cancer Gene Studies$137,376
K07 · FY2004 · CA
Statistical Genetic Methods for Cancer Gene Studies$137,376
K07 · FY2003 · CA
Statistical Genetic Methods for Cancer Gene Studies$134,137
K07 · FY2002 · CA